Mechanistic approach to stability studies as a tool for the optimization and development of new products based on L. rhamnosus Lcr35® in compliance with current regulations

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Muller, Claudia ^a,b   Busignies, Virginie ^b   Mazel, Vincent ^b   Forestier, Christiane ^c   Nivoliez, Adrien ^a   Tchoreloff, Pierre ^b  

^a Probionov   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ BLAISE PASCAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACILOR; LCR RESTITUO; LCR35; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARRHENIUS MODEL; ARTICLE; BACTERIAL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG QUALITY; DRUG SCREENING; DRUG STABILITY; LACTOBACILLUS RHAMNOSUS; MEASUREMENT ACCURACY; MICROBIAL SENSITIVITY TEST; MODEL; NONHUMAN; POWDER; STORAGE; TEMPERATURE;

HUMANS; LACTOBACILLUS RHAMNOSUS; MODELS, BIOLOGICAL; PRESERVATION, BIOLOGICAL; PROBIOTICS; TIME FACTORS;

EID: 84892976586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079041     Document Type: Article

References (35)

1. FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. Working group report. Rome and Geneva: Food and Agricultural Organization of the United Nation/World Health Organization.
2. Kaur IP, Chopra K, Saini A (2002) Probiotics: potential pharmaceutical applications. Eur. J. Pharm. Sci. 15: 1-9. (Pubitemid 34136963)
3. Ouwehand AC, Salminen SJ (1998) The health effects of cultured milk products with viable and non-viable bacteria. Int. Dairy J. 8: 749-758. (Pubitemid 29114455)
4. Quigley EMM (2010) Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol. Res. 61: 213-218.
5. Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T (2000) Probiotic bacteria : safety, functional and technological properties. J. Biotechnol. 84: 197-215.
6. Scheinbach S (1998) Probiotics: functionality and commercial status. Biotechnol. Adv. 16 (3): 581-608.
7. Kailasapathy K, Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol. 78: 80-88.
8. Forssten SD, Sindelar CW, Ouwehand AC (2011) Probiotics from an industrial perspective. Anaerobe 17: 410-413.
9. Kosin B, Rakshit SK (2006) Criteria for production of probiotics. Food Technol. Biotech. 44 (3): 371-379.
10. Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S (2001) Quality assurance criteria for probiotic bacteria. Am. J. Cli. Nutr. 73 (suppl): 393S-398S.
11. Cerf O, Davey KR, Sadoudi AK (1996) Thermal inactivation of bacteria-a new predictive model for the combined effect of three environmental factors: temperature, pH and water activity. Food Res. Int. 29 (3-4): 219-226. (Pubitemid 27088555)
12. Chan ES, Zhang Z (2002) Encapsulation of probiotic bacteria Lactobacillus acidophilus by direct compression. Trans IChem E 80: Part C.
13. Grześkowiak Ł, Isolauri E, Salminen S, Gueimonde M (2010) Manufacturing process influences properties of probiotic bacteria. Brit. J. Nutr.: 1-8.
14. Makinen K, Berger B, Bel-Rhild R, Ananta E (2012) Science and technology for the mastership of probiotic applications in food products. J. Biotechnol. 162: 356-365.
15. Oliveira MN, Sodini I, Remeuf F, Corrieu G (2001) Effect of milk supplementation and culture composition on acidification, textural properties and microbiological stability of fermented milks containing probiotic bacteria. Int. Dairy J. 11: 935-942. (Pubitemid 34060569)
16. Savini M, Cecchini C, Verdenelli MC, Silvi S, Orpianesi C, et al. (2010) Pilot-scale production and viability analysis of freeze-dried probiotic bacteria using different protective agents. Nutrients 2: 330-339.
17. Zarate G, Nader-Macias ME (2006) Viability and biological properties of probiotic vaginal lactobacilli after lyophilization and refrigerated storage into gelatin capsules. Process Biochem. 41: 1779-1785. (Pubitemid 43767161)
18. CPMP/ICH/2736/99, ICH Q1A (R2) (2003) Note for guidance on stability testing: Stability testing of new drug substances and products. European Medicines Agency.
19. Davey KR (1993) Linear-Arrhenius models for bacterial growth and death and vitamin denaturations. J. Ind. Microbiol. 12: 172-179.
20. Slater JG, Stone HA, Palermo BT, Duvall RN (1979) Reliability of Arrhenius Equation in Predicting Vitamin A Stability in Multivitamin Tablets. J. Pharm. Sci. 68: 49-52. (Pubitemid 9100617)
21. La Saponara, V (2011) Environmental and chemical degradation of carboxy/epoxy and structural adhesive for aerospace applications: Fickian and anomalous diffusion, Arrhenius kinetics. Compos. Struct. 93: 2180-2195.
22. Waterman KC (2011) The application of the Accelerated Assessment Program (ASAP) to Quality by Design (QbD) for Drug Product Stability. AAPS PharmSciTech 3 (12): 932-937.
23. CHMP/ICH/167068/04, ICH Q8(R2) (2009) Pharmaceutical development. European Medicines Agency.
24. Koutsoumanis K, Stamatiou A, Skandamis P, Nychas GJE (2006) Development of a microbial model for the combined effect of temperature and pH on spoilage of ground meat, and validation of the model under dynamic temperature conditions. Applied environ. microb. 72 (1): 124-134.
25. Madras G, Chattopadhyay S (2001) Optimum temperature for oxidative degradation of poly(vinyl acetate) in solution. Chem. Eng. Sci. 56: 5058-5089.
26. Carvalho AS, Silva J, Ho P, Teixeira P, Malcata FX, et al. (2004) Relevant factors for the preparation of freeze-dried lactic acid bacteria. Int. Dairy J. 14: 835-847. (Pubitemid 39081551)
27. Forestier C, De Champs C, Vatoux C, Joly B (2001) Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 152: 167-173. (Pubitemid 32222962)
28. Petricevic L, Witt A (2008) The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 115 (11): 1369-1374.
29. Coudeyras S, Jugie G, Vermerie M, Forestier C (2008) Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect. Dis. Obstet. Gynecol.: 549640.
30. Coudeyras S, Marchandin H, Fajon C, Forestier C (2008) Taxonomic and strain-specific identification of the probiotics strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group. Appl. Environ. Microb.: 2679-2689.
31. Nivoliez A, Camares O, Paquet-Gachinat M, Bornes S, Forestier C, et al. (2012) Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®. J. Biotechnol. 160: 236-241.
32. Berner D, Viernstein H (2006) Effect of protective agents on the viability of Lactococcus lactis to freeze-thawing and freeze-drying. Sci. Pharm. 74: 137-149. (Pubitemid 44701576)
33. Jennison MW, Wadsworth GP (1940) Evaluation of the errors involved in estimating bacterial numbers by the plating method. J. Bacteriol. 39(4): 389-397.
34. Sutton S (2011) Accuracy of plate counts. Journal of validation technology 3 (17): 42-46.
35. Waterman KC, Adami RC (2005) Accelerated aging: Prediction of chemical stability of pharmaceuticals. Int. J. Pharm. 293: 101-125. (Pubitemid 40381085)